PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu(University of Pennsylvania), Shujing Liu(University of Pennsylvania), Gao Zhang(The Wistar Institute), Bin Wu(University of Pennsylvania), Yueyao Zhu(University of Pennsylvania), Dennie T. Frederick(Massachusetts General Hospital), Yi Hu(Drexel University), Wenqun Zhong(University of Pennsylvania), Sergio Randell(The Wistar Institute), Norah Sadek(The Wistar Institute), Wei Zhang(University of Pennsylvania), Gang Chen(University of Pennsylvania), Chaoran Cheng(New Jersey Institute of Technology), Jingwen Zeng(University of Pennsylvania), Lawrence W. Wu(The Wistar Institute), Jie Zhang(New Jersey Institute of Technology), Xiaoming Liu(University of Pennsylvania), Wei Xu(University of Pennsylvania), Clemens Krepler(The Wistar Institute), Katrin Sproesser(The Wistar Institute), Min Xiao(The Wistar Institute), Benchun Miao(Massachusetts General Hospital), Jianglan Liu(The Wistar Institute), Claire Song(University of Pennsylvania), Jephrey Y. Liu(University of Pennsylvania), Giorgos C. Karakousis(Hospital of the University of Pennsylvania), Lynn M. Schuchter(University of Pennsylvania), Yiling Lu(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Yu‐Sheng Cong(Hangzhou Normal University), Jonathan Chernoff(Fox Chase Cancer Center), Jun Guo(Peking University Cancer Hospital), Genevieve M. Boland(Massachusetts General Hospital), Ryan J. Sullivan(Massachusetts General Hospital), Zhi Wei(New Jersey Institute of Technology), Jeffrey Field(Translational Therapeutics (United States)), Ravi K. Amaravadi(Hospital of the University of Pennsylvania), Keith T. Flaherty(Massachusetts General Hospital), Meenhard Herlyn(The Wistar Institute), Xiaowei Xu(University of Pennsylvania), Wei Guo(University of Pennsylvania)
Cited by 170
Abstract
Related Papers
No related papers found
Powered by citation graph analysis